Specialties
Cardiology
Chronic Disease
Dermatology
Emergency
Endocrinology
Gastroenterology
Imaging and Intervention
Infectious Disease
Nephrology
Neurology
Obstetrics
Oncology
Ophthalmology
Pediatrics
Preclinical
Psychiatry
Public Health
Pulmonology
Surgery
Urology
Classics™
Rewinds
Click for the Rewinds Archive
Power Rankings™
Patients
Subscribe
Write for Us
Writer Application
Submit an Opinion
For Partners
License Content
Submit Press Release
Advertise with Us
Search
Sunday, August 18, 2019
About
Masthead
License Content
Advertise
Submit Press Release
RSS/Email List
Write for us
Contact us
2 Minute Medicine
Specialties
All
Cardiology
Chronic Disease
Dermatology
Emergency
Endocrinology
Gastroenterology
Imaging and Intervention
Infectious Disease
Nephrology
Neurology
Obstetrics
Oncology
Ophthalmology
Pediatrics
Preclinical
Psychiatry
Public Health
Pulmonology
Surgery
Urology
Quick Take: Association of hearing loss with dementia
Quick Take: Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for…
The PREVENT trial: eculizumab reduces relapse risk in patients with neuromyelitis…
Excess body fat is a major risk factor for premature death…
Classics™
Rewinds
2 Minute Medicine Rewind August 5, 2019
2 Minute Medicine Rewind July 15, 2019
2 Minute Medicine Rewind July 29, 2019
2 Minute Medicine Rewind July 22, 2019
2 Minute Medicine Rewind July 8, 2019
Click for the Rewinds Archive
Power Rankings™
Patients
Subscribe
Write for Us
Writer Application
Submit an Opinion
For Partners
License Content
Submit Press Release
Advertise with Us
Tag: icosapent ethyl
#VisualAbstract: Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
Study Graphics | Constance Wu
-
January 11, 2019
0
The REDUCE-IT trial: Icosapent ethyl reduces ischemic event risk in patients...
Dayton McMillan
-
January 5, 2019
0
All-time hits
The Child-Pugh score: Prognosis in chronic liver disease and cirrhosis [Classics...
July 16, 2013
The CLOT trial: Dalteparin versus warfarin [Classics Series]
December 7, 2014
Updated JNC 8 guidelines for antihypertensive drugs released
December 19, 2013
